Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for May 2005
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Pharma and biotech target growing cancer sector
ASCO conference highlights importance..(more)

 Pfizer becomes competitive in oncology
Pfizer unveils kidney drug Sutent..(more)

 NHS reforms turn to 'family health services'
Hewitt wants bottom-up change..(more)

 Industry and agencies pour cold water on global procurement
Global approach not always ideal..(more)

 Shire plans four key drug filings
Shire reviews R&D pipeline..(more)

 Smoking vaccine company seeks big pharma partner
Obesity and hypertension vaccines next step..(more)

 Strutt appointed to Crestor global PR role
AstraZeneca maintains Crestor defence..(more)

 Hewitt to press ahead with NHS reform
Private sector set to play bigger role..(more)

 FDA approves Requip for restless legs syndrome
First RLS drug to receive US approval..(more)

 Novartis files novel iron overload treatment
Exjade granted fast-track status..(more)

 Roche raise sales expectations
Cancer drugs lead the way..(more)

 Monoclonal antibody sales set to rocket
Sales set to reach $30 billion by 2010..(more)

 Crestor sales top $1 billion for AstraZeneca
Crestor fights off safety concerns ..(more)

 Gilmartin to leave troubled Merck
Interim executive committee appointed..(more)

 GSK makes strategic biotech acquisition
Analysts positive about Corixa acquisition..(more)

 Charity aiming to 'hit diabetes for six'
Fitting tribute to Stephanie Marks ..(more)

 Health helps Labour win third term
John Reid hails Labour's handling of NHS..(more)

 Lilly's first-in-class diabetes drug approved in US
Novo Nordisk rival in phase II stage..(more)

 Mixed news for AstraZeneca's stroke drug Cerovive
Drug prevents disability but no neurological benefits shown..(more)

 Cholesterol drugs boost Schering-Plough
Older drugs perform well..(more)

 EMEA advises against prescribing of antidepressants in children
New recommendations discourage prescribing SSRIs and Wyeth's Efexor..(more)

 Velcade moves up to second line treatment
Ortho Biotech's cancer treatment receives new European indication..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.